Protocol Ledger

NCT05465174 · Phase II · RECRUITING

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Interventional Phase II clinical trial protocol NCT05465174 sponsored by Sabine Mueller, MD, PhD in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-09-12 Enrollment: 57 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05465174
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)57 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05465174
Protocol FieldVerified Registry Value
NCT IdentifierNCT05465174
Consolidated Lead SponsorSabine Mueller, MD, PhD
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment57 participants (ESTIMATED)
Registered Start Date2022-09-12
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI